This article has been updated to clarify that Roche's HPV assay is the only one on the market with an FDA-approved primary screening indication, and not the only FDA-approved HPV test on the market.

NEW YORK (GenomeWeb) – The US Preventative Services Task Force has issued draft recommendations proposing that women in their 20s be screened for cervical cancer every three years with cervical cytology alone. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.